Etoposide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Etoposide.
| Product ID | 0378-3266_a591eea6-af04-4207-b0f7-61fbada4719c |
| NDC | 0378-3266 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Etoposide |
| Generic Name | Etoposide |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2001-10-22 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA075635 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ETOPOSIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2001-10-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA075635 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2001-10-22 |
| Ingredient | Strength |
|---|---|
| ETOPOSIDE | 50 mg/1 |
| SPL SET ID: | 508a418e-985f-4208-9324-2230655bb5c2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9376 | Etoposide | Etoposide |
| 0143-9510 | Etoposide | Etoposide |
| 0143-9511 | Etoposide | Etoposide |
| 0143-9512 | Etoposide | Etoposide |
| 0378-3266 | Etoposide | etoposide |
| 16729-114 | Etoposide | Etoposide |
| 16729-262 | Etoposide | Etoposide |
| 63323-104 | Etoposide | ETOPOSIDE |
| 68001-265 | Etoposide | Etoposide |
| 0703-5653 | Toposar | Etoposide |
| 0703-5656 | Toposar | Etoposide |
| 0703-5657 | Toposar | Etoposide |